Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 1997

View Archived Issues

NCI study indicates potential teratogenicity of AZT

Abbott isolates fusacandin antifungal agents

Daikin synthesizes new ganglioside compounds

New ACAT inhibitors claimed by DuPont Merck

Heterocyclic MDR inhibitors reported by Pfizer

Mayo Foundation reports new natriuretic peptide

Anti-IL-2 monoclonal antibody described by Ajinomoto

More antiobesity proteins in the pipeline at Lilly

cAMP PDE inhibitors disclosed by Nippon Kayaku

Aquila adjuvant shows promise as component of malaria vaccine

New wound-healing agents reported

New amylin antagonists from Amylin

Faulding expands into Europe

Phase II trials begin on ICOS MS treatment

EntreMed licenses dual cytotoxic/antiangiogenic compound

Troglitazone price-listed in Japan

JT to launch new imaging agent soon in Japan

Takeda claims new approach to diabetes Rx

Triangle reports preliminary clinical results with anti-HIV compound

Mochida claims new formulation for ulinastatin

IVAX and Knoll modify European alliance

Adeza obtains clearance for supplementary PMA

Forbes files for U.S. patent related to membrane deficiencies

Zeneca's right to sell prostate cancer drug upheld

Medtronic's arrhythmia management device enters clinic

Olopatadine studied for allergic conjunctivitis

BMS antidepressant chosen for important multiinstitutional trial

Ibopamine efficacy in patients with chronic progressive renal failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...